Digital Transformation: The best foot forward for pharma The pharmaceutical industry existed long before we were introduced to our first dose of digital. But, to what extent is the pharmaceutical industry adapting to the times? And how are executives future proofing their business models in an ever-changing digital sphere? Digital
Where will medical affairs create the most industry value? Through our engagement with clients, new business consultations, and SMEs, we at Intuition are constantly learning about how Medical Affairs (MA) continues to evolve and refine the industry’s approach to some of its most critical scientific manufacturing and communication processes. A recent publication by GOLD highlighted
Learning & Development Under The Microscope Volume 2 - GxP System Validation In many respects, 2022 was a year of hard-fought inches. Amid all the ecstasy and buzzkill, organizations within the life-sciences space have kept their footing – a difficult balancing act all things considered – as industry foundations
How HCP education can drive your Medical Affairs strategy Medical Affairs (MA) teams within life sciences organizations are responsible for communicating scientific and clinical information to relevant stakeholders, including HCPs, patients, and internal stakeholders such as Medical Science Liaisons (MSLs). Most roles that MA teams now occupy were previously filled by the commercial side
Medical affairs transformation - The power of technology The past three years have reshaped perspectives on the pharmaceutical industry and the real-time adaptability that underpins its clinical processes. Testament to the durability of the scientific method, the efforts of private interest, and a handful of key pharmaceutical stakeholders, the industry has paved the way in
Five human skills needed in Medical Affairs“The value of the Medical Affairs function is dependent on understanding customers’ needs and providing the right knowledge at the right time to physicians”Medical Affairs is quickly becoming one of the most strategically important functions across life sciences companies, and the remit of Medical Affairs professionals is expanding significantly.
The future of Telehealth: From pandemic expansion to present-day adoption The pandemic forced the widespread adoption of remote communication upon a largely ill-prepared global workforce. Areas that lacked modern advancement had to quickly adjust to the transition to an online working existence. Schools and workplaces turned to the digital communication features on their
Learning & Development Under the Microscope Volume 1 The Life-Sciences industry is constantly evolving under the pressure of new expectations. Regulators expect more transparency, consumers expect constant therapeutic advancement, while employees internal to these questions want more in return for the cost of shouldering that burden. It is a
Digital Therapeutics and Their Role in the Future of Modern Medicine Technology conveniences us at every turn. It empowers our behaviors and crystalises our understanding for the world through the tools we use to interact with it. We crutch our livelihoods on these systems, and depend on their advancement as our needs change, and our
Education as a strategy - Redefining emerging market access in pharmaceuticals “Impatience” is often cited as a major shortcoming among pharmaceutical companies trying their hand at emerging markets. The opportunity as discussed in theory, typically depicts the potential growth these countries have to offer, while the reality rarely presents itself so clearly. Emerging markets
